Primary Site >> Liver Cancer

Gene >> RSPO2

Journal: Hepatology. 2014 Dec;60(6):1972-82.
Title: Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.
Author: Ahn, Sung-Min|Jang, Se Jin|Shim, Ju Hyun|Kim, Deokhoon|Hong, Seung-Mo|Sung, Chang Ohk|Baek, Daehyun|Haq, Farhan|Ansari, Adnan Ahmad|Lee, Sun Young|Chun, Sung-Min|Choi, Seongmin|Choi, Hyun-Jeung|Kim, Jongkyu|Kim, Sukjun|Hwang, Shin|Lee, Young-Joo|Lee, Jong
PMID: 24798001
Journal: Biomed Pharmacother. 2017 Sep;93:334-343.
Title: MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2).
Author: Xu, Yuqiang|Ge, Kuikui|Lu, Junhao|Huang, Jinjiang|Wei, Wei|Huang, Qingshan
PMID: 28651234
Journal: Oncol Lett. 2017 Aug;14(2):1757-1765.
Title: R-spondin 2 promotes proliferation and migration via the Wnt/beta-catenin pathway in human hepatocellular carcinoma.
Author: Yin, Xinguang|Yi, Huixing|Wang, Linlin|Wu, Wanxin|Wu, Xiaojun|Yu, Linghua
PMID: 28789406